Difference between revisions of "VEGFR-2"
(New page: {| class="toccolours" border="1" style="float: left; clear: right; margin: 0 0 1em 1em; border-collapse: collapse;" ! {{infobox header}}| '''{{PAGENAME}}''' |- | align="center" colspan="2...) |
m |
||
| Line 44: | Line 44: | ||
|- | |- | ||
| Notes | | Notes | ||
| − | | Blocking the transglutaminase activity of TG2 prevents the VEGF-induced translocation of VEGFR-2 into the nucleus | + | | Blocking the transglutaminase activity of TG2 prevents the VEGF-induced |
| + | translocation of VEGFR-2 into the nucleus | ||
|- | |- | ||
| {{infobox header}} | | | {{infobox header}} | | ||
Revision as of 10:06, 20 September 2007
| Template:Infobox header| VEGFR-2 | |
|---|---|
| Substrate peptide name | VEGFR-2 |
| Synonyms | - |
| Determination type | In situ |
| Source | Homo sapiens |
| Subcellular localization | Plasma membrane, nucleus |
| Swissprot ID | P35968 |
| Reactive glutamines | Not determined yet |
| Reactive lysines | - |
| Substrate sequence | |
| Structure | 1Y6A |
| Surface accessibility | |
| Disorder prediction | IUPred |
| Reference | PMID:16914140 |
| Notes | Blocking the transglutaminase activity of TG2 prevents the VEGF-induced
translocation of VEGFR-2 into the nucleus |
| Template:Infobox header | | |
